Physician profile
Tamara Frederick
NPI 1679738025
$1,773.10
in general payments reported to CMS, 2019-2025
15 companies · $76.92 in 2025
The $76.92 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,175 · 2022: $296 · 2023: $113 · 2024: $113 · 2025: $76.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $502.18 | 2021-2024 | |
| Vyne Pharmaceuticals INC. | $269.42 | 2021 | |
| Janssen Biotech, INC. | $263.47 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $161.32 | 2021 | |
| Incyte Corporation | $116.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $108.20 | 2021-2022 | |
| Genzyme Corporation | $101.92 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $93.70 | 2021 | |
| Amgen INC. | $28.75 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.71 | 2021 | |
| Dermira, INC. | $22.71 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.54 | 2021 | |
| Ucb, INC. | $21.30 | 2021 | |
| Mayne Pharma Commercial LLC | $17.53 | 2021 | |
| Epi Health, LLC | $16.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.